Methods of using IL-1 antagonists to treat autoinflammatory disease

Details for Australian Patent Application No. 2005249570 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Papadopoulos, Joanne; Mellis, Scott; Karow, Margaret; Yancopoulos, George D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005249570

PCT Pub. Number WO2005/117945

Priority 60/577,023 04.06.04 US

Filing date 3 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 16 June 2011

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117945 Priority application(s): WO2005/117945

16 June 2011 Application Accepted

  Published as AU-B-2005249570

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249571-Methods for preparing immunogenic conjugates

2005249567-Compositions containing opioid antagonists